Cancer , known medically as a malignant neoplasm, is a broad group of diseases involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumors, and invade nearby parts of the body. The cancer may also spread to more distant parts of the body through the lymphatic system or bloodstream. Not all tumors are cancerous; benign tumors do not invade neighboring tissues and do not spread throughout the body. There are over 200 different known cancers that affect humans.
The causes of cancer are diverse, complex, and only partially understood. Many things are known to increase the risk of cancer, including tobacco use, dietary factors, certain infections, exposure to radiation, lack of physical activity, obesity, and environmental pollutants. [2] These factors can directly damage genes or combine with existing genetic faults within cells to cause cancerous mutations. Approximately 5–10% of cancers can be traced directly to inherited genetic defects.
[4] Many cancers could be prevented by not smoking, eating more vegetables, fruits and whole grains, eating less meat and refined carbohydrates, maintaining a healthy weight, exercising, minimizing sunlight exposure, and being vaccinated against some infectious diseases. Cancer can be detected in a number of ways, including the presence of certain signs and symptoms, screening tests, or medical imaging. Once a possible cancer is detected it is diagnosed by microscopic examination of a tissue sample. Cancer is usually treated with chemotherapy, radiation therapy and surgery.
The chances of surviving the disease vary greatly by the type and location of the cancer and the extent of disease at the start of treatment. While cancer can affect people of all ages, and a few types of cancer are more common in children, the risk of developing cancer generally increases with age. In 2007, cancer caused about 13% of all human deaths worldwide (7. 9 million). Rates are rising as more people live to an old age and as mass lifestyle changes occur in the developing world. The One Who Discovered Pancreatic Cancer.
We say some diseases are “discovered” by individuals because they have recognised a combination of symptoms, physical signs and an outcome or prognosis as related (ie they “put it all together”) where no one has clicked to this before. This has mainly happened for rare diseases (common ones have been understood for a long time by many people) and in the nineteenth and twentieth centuries (because of increasing knowledge of medicine and increasing population — more people have the rare disease). Pancreatic cancer often causes jaundice. This is yellow skin and is an obvious sign.
Ancient physicians in Egypt, Greece, China, etc. would have recognised this and linked it with a poor outcome. However, there is no record that they understood it was due to a tumour deep inside the abdomen, specifically the pancreas. So they had a partial grasp of the disease. It was only when examining dead bodies was acceptable culturally did people find these tumours. One of the early “pathologists”, but not necessarily the first, to find these tumours was Giovanni Battista Morgagni (1682-1771). So, in answer to your question, no single person discovered pancreatic cancer.
The Genetics of Pancreatic Cancer This section has been reviewed and approved by the Cancer. Net Editorial Board, 4/2011 What are genes? Genes carry information within each cell of the human body. Researchers estimate that there are 30,000 different genes in each cell. Genes are packaged onto chromosomes. There are 23 pairs of chromosomes in each cell. One chromosome of each pair is inherited from the person’s father and one from the person’s mother. Genes control how a cell functions, including how quickly it grows, how often it divides, and how long it lives.
To control these functions, genes produce proteins that perform specific tasks and act as messengers for the cell. Therefore, it is essential that each gene have the correct instructions or “code” for making its protein so that the protein can perform the proper function for the cell. What role do genes play in pancreatic cancer? Many cancers begin when one or more genes in a cell are mutated (changed), creating an abnormal protein or no protein at all. The information provided by an abnormal protein is different from that of a normal protein, which can cause cells to multiply uncontrollably and become cancerous.
A person may either be born with a genetic mutation in all of their cells (germline mutation) or acquire a genetic mutation in a single cell during his or her lifetime. An acquired mutation is passed on to all cells that develop from that single cell (called a somatic mutation). Somatic mutations can sometimes be caused by environmental factors, such as cigarette smoke. Most pancreatic cancers (about 90%) are considered sporadic, meaning that the damage to the genes occurs by chance after a person is born and there is no risk of passing on the gene to a person’s children.
Inherited pancreatic cancers are less common (about 10%) and occur when gene mutations are passed within a family, from one generation to the next. What are the chances a mutated gene is inherited? Every cell usually has two copies of each gene: one inherited from a person’s mother and one inherited from a person’s father. Most types of hereditary pancreatic cancer follow an autosomal dominant inheritance pattern, in which a mutation needs to happen in only one copy of the gene for the person to have an increased risk of getting the disease.
This means that a parent with a gene mutation may pass on a copy of the normal gene or a copy of the gene with a mutation. Therefore, a child who has a parent with a mutation has a 50% chance of inheriting that mutation. A brother, sister, or parent of a person who has a gene mutation also has a 50% chance of having the same mutation. What is a person’s average risk for pancreatic cancer? A person with an average risk of pancreatic cancer has less than a 1% chance of developing pancreatic cancer sometime during his or her life.
How can a person know if he or she has inherited a genetic mutation that increases his or her risk of pancreatic cancer? Only genetic testing can determine whether a person has a genetic mutation. Most experts strongly recommend that people considering genetic testing first talk with a genetic counselor. Genetic counselors are trained to explain the risks and benefits of genetic testing. How does a person know if pancreatic cancer runs in the family? Pancreatic cancer runs in a family when two or more first-degree relatives (parents, brothers, sisters, children) are diagnosed with pancreatic cancer.
This is sometimes called familial pancreatic cancer. Families with three or more close relatives (first-degree relatives, grandparents, aunts, uncles, nieces, nephews, grandchildren, cousins) diagnosed with pancreatic cancer, and with one relative diagnosed before age 50, are also considered to have familial pancreatic cancer. What is a person’s risk if pancreatic cancer runs in the family? If a person has a first-degree relative with pancreatic cancer, his or her risk of developing the disease is much higher than the average person’s risk.
The National Institutes of Health (NIH) estimates that the risk of developing pancreatic cancer is increased four to five times for a person with one first-degree relative with pancreatic cancer, six to seven times for a person with two first-degree relatives, and 32 times for a person with three first-degree relatives with the disease. Which inherited genetic mutations raise the risk of pancreatic cancer? There are several genetic conditions associated with an increased risk of pancreatic cancer. The most common hereditary syndromes linked with increased pancreatic cancer risk are described below.
Hereditary pancreatitis (HP). HP is a condition that is associated with recurrent pancreatitis (inflammation or swelling of the pancreas) and pancreatic cancer. It can begin in childhood and become worse over time. Peutz-Jeghers syndrome (PJS). PJS is caused by a specific genetic mutation and is associated with multiple polyps in the digestive tract that become noncancerous tumors, increased pigmentation (dark spots on the skin) on the face and hands, and an increased risk ofcolorectal, pancreatic, breast, uterine, ovarian, and lung cancers.
Familial malignant melanoma and pancreatic cancer (FAMM-PC). FAMM-PC is associated with a specific genetic mutation. Families with FAMM-PC have an increased risk of melanoma and pancreatic cancer. Hereditary breast and ovarian cancer (HBOC) syndrome. HBOC is associated with mutations in the BRCA1 and/or BRCA2 (BRCA stands for BReast CAncer). Women with HBOC have an increased risk of breast cancer and ovarian cancer. Men with HBOC have an increased risk ofbreast cancer and prostate cancer.
People with HBOC also have an increased risk of pancreatic cancer, specifically people who have a mutation on the BRCA2 gene but a BRCA1 mutation may also cause a small increased risk. Lynch Syndrome. Lynch syndrome is caused by mutations in several different genes and increases the risk of colorectal cancer, as well as cancers of the stomach, small intestine, liver, bile duct, urinary tract, the brain and central nervous system, pancreas, and possibly breast. Other forms of familial pancreatic cancer. Research to find other genes associated with familial pancreatic cancer is ongoing.
Families in which more than one person has developed pancreatic cancer who do not have any other signs of a specific hereditary cancer syndrome may consider participating in clinical trials to help researchers learn more about pancreatic cancer genes. A genetic counselor can help you and your family find such studies. Are there other genetic conditions associated with an increased risk of pancreatic cancer? The hereditary cancer syndromes described below may also increase a person’s risk of pancreatic cancer.
If you are concerned about your family history, talk with your doctor or genetic counselor to learn more. As research continues, doctors may learn more about the causes of inherited pancreatic cancer. Li-Fraumeni syndrome (LFS). LFS is a rare condition associated with a specific genetic mutation. People with LFS have a higher risk of developing osteosarcoma, soft tissue sarcoma, leukemia, breast cancer, brain cancer, and adrenal cortical tumors. People with LFS have developed pancreatic cancer, but the risk of developing the disease is not known.
Familial adenomatous polyposis (FAP). People with FAP often develop polyps (a growth in the colon or rectum) that are noncancerous at first, but eventually develop into cancer if not treated. FAP is caused by a specific genetic mutation that increases the risk of developingcolorectal cancer and other types of cancer, such as stomach, small intestine, pancreas, thyroid, and hepatoblastoma (liver cancer that usually occurs in early childhood). What is your risk level? In addition to family history, other environmental and lifestyle factors may increase your risk of pancreatic cancer.
Discussing your family history and personal risk factors with a doctor can help you better understand your risk. People with a higher than average risk may benefit from genetic counseling. There is no standard procedure for screening either the general population or people with an increased risk of pancreatic cancer. However, researchers are studying high resolution computed tomography (CT or CAT) scanning, endoscopicultrasound, and endoscopic retrograde pancreatocholangiography (also called endoscopic retrograde cholangiopancreatography or ERCP) as possible screening methods.
Learn more about possible screening methods for pancreatic cancer. A risk factor is anything that increases a person’s risk of developing cancer. Having a particular genetic mutation linked to pancreatic cancer does not mean that a person will develop cancer. Controllable risk factors, such as eating a balanced diet, maintaining a healthy weight, exercising, limiting alcoholic beverages, and avoiding tobacco products also play a role. Smoking is the biggest controllable risk factor for pancreatic cancer. Although, some people who develop pancreatic cancer have few known risk factors.
Research continues to help doctors better understand the risk between genetic mutations and pancreatic cancer. Talk with a doctor for more information about risk factors and prevention for pancreatic cancer. PANCREATIC CANCER FACTS An estimated 45,220 Americans will be diagnosed with pancreatic cancer in the U. S. , and over 38,460 will die from the disease. Pancreatic cancer is one of the few cancers for which survival has not improved substantially over nearly 40 years. Pancreatic cancer is the 4th leading cause of cancer-related death in the United States.
Pancreatic cancer has the highest mortality rate of all major cancers. 94% of pancreatic cancer patients will die within five years of diagnosis – only 6% will survive more than five years. 74% of patients die within the first year of diagnosis. The average life expectancy after diagnosis with metastatic disease is just three to six months. Few risk factors for developing pancreatic cancer are defined. Family history of the disease, smoking, age, and diabetes are risk factors. Pancreatic cancer may cause only vague symptoms that could indicate many different conditions within the abdomen or gastrointestinal tract.
Symptoms include pain (usually abdominal or back pain), weight loss, jaundice (yellowing of the skin and eyes), loss of appetite, nausea, changes in stool, and diabetes. Treatment options for pancreatic cancer are limited. Surgical removal of the tumor is possible in less than 20% of patients diagnosed with pancreatic cancer. Chemotherapy or chemotherapy together with radiation is typically offered to patients whose tumors cannot be removed surgically.
Only three drugs are FDA? approved for the treatment of pancreatic cancer: fluorouracil (5?FU), gemcitabine (Gemzar®), and erlotinib (Tarceva®). Pancreatic cancer is a leading cause of cancer death largely because there are no detection tools to diagnose the disease in its early stages when surgical removal of the tumor is still possible. The National Cancer Institute (NCI) spent an estimated $105. 3 million on pancreatic cancer research in 2012. This represented a mere 1. 8% of the NCI’s approximate $5. 8 billion cancer research budget for that year.
Reference: http://en. wikipedia. org/wiki/Cancer http://www. cancer. net/all-about-cancer/genetics/genetics-pancreatic-cancer.